Complete radiological response when using pembrolizumab in the mono mode in the 2nd-line drug therapy of MSI-h / dMMR-positive advanced endometrial cancer. A clinical case

A. D. Darenskaya; B. M. Medvedeva; A. A. Rumyantsev; A. S. Tyulyandina

Surgery and Oncology

ISSN 2949-5857 (Online)

User

eng | рус

Surgery and Oncology

Advanced search

Archives

Download this PDF file

Fullscreen

Views PDF (Rus): 195

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2949-5857 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Ivan S. Stilidi

Article Tools

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. D. Darenskaya
Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia
Russian Federation

Anna Dmitrievna Darenskaya

24 Kashirskoe shosse, Moscow 115522

B. M. Medvedeva
Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia
Russian Federation

24 Kashirskoe shosse, Moscow 115522

A. A. Rumyantsev
Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia
Russian Federation

24 Kashirskoe shosse, Moscow 115522

A. S. Tyulyandina
Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia; I. M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)
Russian Federation

24 Kashirskoe shosse, Moscow 115522

Build. 2, 8 Trubetskaya St., Moscow 119991

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Surgery and Oncology

Cookies policy